Analysis | Metabolite Name | Measured Value | Units | Gender | Glycemic status | Neuropathy |
---|---|---|---|---|---|---|
Reversed phase POSITIVE ION MODE | OLEOYL-GLYCEROL (M+H)+[-H2O] | 11138 | Peak area normalized | male | Normoglycemic | no neuropathy |
Reversed phase POSITIVE ION MODE | OLEOYL-GLYCEROL (M+H)+[-H2O] | 13177 | Peak area normalized | female | Pre-diabetic | no neuropathy |
Reversed phase POSITIVE ION MODE | OLEOYL-GLYCEROL (M+H)+[-H2O] | 17858 | Peak area normalized | female | Pre-diabetic | no neuropathy |
Reversed phase POSITIVE ION MODE | OLEOYL-GLYCEROL (M+H)+[-H2O] | 18088 | Peak area normalized | male | Diabetic | no neuropathy |
Reversed phase POSITIVE ION MODE | OLEOYL-GLYCEROL (M+H)+[-H2O] | 18422 | Peak area normalized | female | Diabetic | Neuropathy |
Reversed phase POSITIVE ION MODE | OLEOYL-GLYCEROL (M+H)+[-H2O] | 18789 | Peak area normalized | female | Pre-diabetic | Neuropathy |
Reversed phase POSITIVE ION MODE | OLEOYL-GLYCEROL (M+H)+[-H2O] | 18912 | Peak area normalized | female | Pre-diabetic | no neuropathy |
Reversed phase POSITIVE ION MODE | OLEOYL-GLYCEROL (M+H)+[-H2O] | 19324 | Peak area normalized | female | Pre-diabetic | no neuropathy |
Reversed phase POSITIVE ION MODE | OLEOYL-GLYCEROL (M+H)+[-H2O] | 19457 | Peak area normalized | male | Diabetic | no neuropathy |
Reversed phase POSITIVE ION MODE | OLEOYL-GLYCEROL (M+H)+[-H2O] | 21055 | Peak area normalized | male | Pre-diabetic | Neuropathy |
Reversed phase POSITIVE ION MODE | OLEOYL-GLYCEROL (M+H)+[-H2O] | 21579 | Peak area normalized | male | Normoglycemic | Neuropathy |
Reversed phase POSITIVE ION MODE | OLEOYL-GLYCEROL (M+H)+[-H2O] | 21987 | Peak area normalized | female | Pre-diabetic | Neuropathy |
Reversed phase POSITIVE ION MODE | OLEOYL-GLYCEROL (M+H)+[-H2O] | 22654 | Peak area normalized | male | Diabetic | Neuropathy |
Reversed phase POSITIVE ION MODE | OLEOYL-GLYCEROL (M+H)+[-H2O] | 23242 | Peak area normalized | male | Pre-diabetic | Neuropathy |
Reversed phase POSITIVE ION MODE | OLEOYL-GLYCEROL (M+H)+[-H2O] | 24991 | Peak area normalized | male | Diabetic | no neuropathy |
Reversed phase POSITIVE ION MODE | OLEOYL-GLYCEROL (M+H)+[-H2O] | 25130 | Peak area normalized | female | Pre-diabetic | Neuropathy |
Reversed phase POSITIVE ION MODE | OLEOYL-GLYCEROL (M+H)+[-H2O] | 25256 | Peak area normalized | male | Normoglycemic | Neuropathy |
Reversed phase POSITIVE ION MODE | OLEOYL-GLYCEROL (M+H)+[-H2O] | 25307 | Peak area normalized | female | Diabetic | Neuropathy |
Reversed phase POSITIVE ION MODE | OLEOYL-GLYCEROL (M+H)+[-H2O] | 27966 | Peak area normalized | male | Pre-diabetic | no neuropathy |
Reversed phase POSITIVE ION MODE | OLEOYL-GLYCEROL (M+H)+[-H2O] | 30277 | Peak area normalized | female | Pre-diabetic | Neuropathy |
Reversed phase POSITIVE ION MODE | OLEOYL-GLYCEROL (M+H)+[-H2O] | 30983 | Peak area normalized | male | Pre-diabetic | no neuropathy |
Reversed phase POSITIVE ION MODE | OLEOYL-GLYCEROL (M+H)+[-H2O] | 31914 | Peak area normalized | female | Diabetic | no neuropathy |
Reversed phase POSITIVE ION MODE | OLEOYL-GLYCEROL (M+H)+[-H2O] | 33195 | Peak area normalized | male | Normoglycemic | no neuropathy |
Reversed phase POSITIVE ION MODE | OLEOYL-GLYCEROL (M+H)+[-H2O] | 34936 | Peak area normalized | female | Diabetic | no neuropathy |
Reversed phase POSITIVE ION MODE | OLEOYL-GLYCEROL (M+H)+[-H2O] | 42522 | Peak area normalized | male | Diabetic | Neuropathy |
Reversed phase POSITIVE ION MODE | OLEOYL-GLYCEROL (M+H)+[-H2O] | 46118 | Peak area normalized | male | Diabetic | Neuropathy |
Reversed phase POSITIVE ION MODE | OLEOYL-GLYCEROL (M+NA)+ | 126171 | Peak area normalized | female | Pre-diabetic | no neuropathy |
Reversed phase POSITIVE ION MODE | OLEOYL-GLYCEROL (M+NA)+ | 148398 | Peak area normalized | male | Pre-diabetic | no neuropathy |
Reversed phase POSITIVE ION MODE | OLEOYL-GLYCEROL (M+NA)+ | 168506 | Peak area normalized | male | Diabetic | no neuropathy |
Reversed phase POSITIVE ION MODE | OLEOYL-GLYCEROL (M+NA)+ | 177189 | Peak area normalized | male | Diabetic | Neuropathy |
Reversed phase POSITIVE ION MODE | OLEOYL-GLYCEROL (M+NA)+ | 178929 | Peak area normalized | male | Normoglycemic | no neuropathy |
Reversed phase POSITIVE ION MODE | OLEOYL-GLYCEROL (M+NA)+ | 190589 | Peak area normalized | female | Pre-diabetic | no neuropathy |
Reversed phase POSITIVE ION MODE | OLEOYL-GLYCEROL (M+NA)+ | 197243 | Peak area normalized | female | Pre-diabetic | Neuropathy |
Reversed phase POSITIVE ION MODE | OLEOYL-GLYCEROL (M+NA)+ | 197675 | Peak area normalized | male | Diabetic | no neuropathy |
Reversed phase POSITIVE ION MODE | OLEOYL-GLYCEROL (M+NA)+ | 218427 | Peak area normalized | female | Pre-diabetic | no neuropathy |
Reversed phase POSITIVE ION MODE | OLEOYL-GLYCEROL (M+NA)+ | 230875 | Peak area normalized | male | Pre-diabetic | Neuropathy |
Reversed phase POSITIVE ION MODE | OLEOYL-GLYCEROL (M+NA)+ | 238435 | Peak area normalized | female | Pre-diabetic | Neuropathy |
Reversed phase POSITIVE ION MODE | OLEOYL-GLYCEROL (M+NA)+ | 241107 | Peak area normalized | female | Pre-diabetic | no neuropathy |
Reversed phase POSITIVE ION MODE | OLEOYL-GLYCEROL (M+NA)+ | 254569 | Peak area normalized | male | Diabetic | no neuropathy |
Reversed phase POSITIVE ION MODE | OLEOYL-GLYCEROL (M+NA)+ | 263233 | Peak area normalized | male | Pre-diabetic | Neuropathy |
Reversed phase POSITIVE ION MODE | OLEOYL-GLYCEROL (M+NA)+ | 263682 | Peak area normalized | male | Normoglycemic | Neuropathy |
Reversed phase POSITIVE ION MODE | OLEOYL-GLYCEROL (M+NA)+ | 267304 | Peak area normalized | female | Diabetic | Neuropathy |
Reversed phase POSITIVE ION MODE | OLEOYL-GLYCEROL (M+NA)+ | 317789 | Peak area normalized | male | Diabetic | Neuropathy |
Reversed phase POSITIVE ION MODE | OLEOYL-GLYCEROL (M+NA)+ | 325251 | Peak area normalized | female | Diabetic | Neuropathy |
Reversed phase POSITIVE ION MODE | OLEOYL-GLYCEROL (M+NA)+ | 329625 | Peak area normalized | male | Pre-diabetic | no neuropathy |
Reversed phase POSITIVE ION MODE | OLEOYL-GLYCEROL (M+NA)+ | 331314 | Peak area normalized | male | Normoglycemic | Neuropathy |
Reversed phase POSITIVE ION MODE | OLEOYL-GLYCEROL (M+NA)+ | 331808 | Peak area normalized | female | Pre-diabetic | Neuropathy |
Reversed phase POSITIVE ION MODE | OLEOYL-GLYCEROL (M+NA)+ | 439938 | Peak area normalized | female | Diabetic | no neuropathy |
Reversed phase POSITIVE ION MODE | OLEOYL-GLYCEROL (M+NA)+ | 473543 | Peak area normalized | female | Diabetic | no neuropathy |
Reversed phase POSITIVE ION MODE | OLEOYL-GLYCEROL (M+NA)+ | 512909 | Peak area normalized | female | Pre-diabetic | Neuropathy |
Reversed phase POSITIVE ION MODE | OLEOYL-GLYCEROL (M+NA)+ | 610257 | Peak area normalized | male | Normoglycemic | no neuropathy |
Reversed phase POSITIVE ION MODE | OLEOYL-GLYCEROL (M+NA)+ | 612582 | Peak area normalized | male | Diabetic | Neuropathy |